Key facts
- This page summarizes John Martin Docherty's Form 4 filing for Lexaria Bioscience Corp. (LEXX).
- 1 reported transaction and 7 derivative rows are listed below.
- Accepted by SEC: 30 Jul 2025, 11:34.
John Martin Docherty - 29 Jul 2025 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)
- Reporting relationship
- President & CSO, Director
- Issuer ticker
- LEXX
- Reported as of
- 29 Jul 2025
- Net transaction value
- +$4,989
- SEC form
- 4
- Accepted by SEC
- 30 Jul 2025, 11:34:10 UTC
- Prior SEC filing
- 16 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /John Docherty/
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
John Martin Docherty filed Form 4 for Lexaria Bioscience Corp. (LEXX) on 30 Jul 2025.
Change
- Previous filing in this sequence was filed on 16 May 2025.
- Current net transaction value: +$4,989.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001638727
Primary reporting owner
DOCHERTY JOHN MARTIN
- Relationship
- President & CSO, Director
- Address
- 23 MIKELEN DRIVE, PORT PERRY, ONTARIO, CANADA
- Signature
- /John Docherty/
- Signature date
- 30 Jul 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LEXX
transaction
common shares
Purchase
- Transaction value
- $4,989
- Shares
- +5,376
- Change %
- Price
- $0.9280
- Shares after
- 5,376
- Date
- 29 Jul 2025
- Ownership
- Direct
LEXX
holding
common shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 54,075
- Date
- 29 Jul 2025
- Ownership
- Private Holding Company
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
LEXX
holding
Derivative
Stock Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 18,000
- Date
- 29 Jul 2025
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 18,000
- Exercise price
- $3.00
LEXX
holding
Derivative
Stock Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 36,334
- Date
- 29 Jul 2025
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 18,334
- Exercise price
- $3.00
LEXX
holding
Derivative
Stock Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 51,334
- Date
- 29 Jul 2025
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 15,000
- Exercise price
- $3.00
LEXX
holding
Derivative
Stock Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 81,334
- Date
- 29 Jul 2025
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 30,000
- Exercise price
- $2.91
LEXX
holding
Derivative
Stock Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 111,334
- Date
- 29 Jul 2025
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 30,000
- Exercise price
- $1.15
LEXX
holding
Derivative
Stock Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 160,834
- Date
- 29 Jul 2025
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 49,500
- Exercise price
- $2.36
LEXX
holding
Derivative
Stock Options
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 310,834
- Date
- 29 Jul 2025
- Ownership
- Direct
- Underlying class
- Common Shares
- Underlying amount
- 150,000
- Exercise price
- $1.04
* marks a reported price that did not pass the local price check.